Safety of FDA-approved drugs [1] (multiple letters)

JAMA

Volumn 282, Issue 24, 1999, Pages 2297-2298

  Lurie, P ^a   Sasich, L D ^a   Friedman, M A ^a   Woodcock, J ^a   Lumpkin, M M ^a   Shuren, J E ^a   Hass, A E ^a   Thompson, L J ^a  

^a Public Citizen Health Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMFENAC; CALCIUM CHANNEL BLOCKING AGENT; MIBEFRADIL; NONSTEROID ANTIINFLAMMATORY AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROGLITAZONE; TROVAFLOXACIN;

DRUG APPROVAL; DRUG INDUCED DISEASE; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEART ARRHYTHMIA; HUMAN; LETTER; LIVER CELL DAMAGE; LIVER DISEASE; LIVER FUNCTION TEST; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL;

EID: 0033596257     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.24.2297     Document Type: Letter

References (0)